Tissue Array
Log In | My Account | Cart (0 items) - $0.00
US Biomax, Inc.
 

LV961

Hepatocellular carcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
Unstained: $185.00 Add to Cart
H&E (LV961s*): $185.00 Add to Cart

Microarray Panel:Hepatocellular carcinoma tissue microarray, containing 25 cases of hepatocellular carcinoma, 3 liver clear cell carcinoma, 4 hepatocholangiocarcinoma, 3 liver metastatic adenocarcinoma, 1 liver leiomyosarcoma, plus 3 normal liver tissue, 2 hepatocellular edema, 3 each of hepatitis and hepatic cirrhosis, 1 liver cavernous hemangioma, duplicate cores per case
Cores:96
Cases:48
Layout:12 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Cytokeratin (CK) confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H & E: Hematoxylin and Eosin stained tissue microarray slide.

Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112 
A Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv  
B Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv  
C Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv  
D Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv  
E Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv  
F Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv  
G Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv  
H Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Liv Marked point
Legend: Liv - Liver

- Benign tumor, - Borderline, - Cirrhosis, - Inflammation, - Malignant tumor, - Malignant tumor (stage I), - Malignant tumor (stage II), - Malignant tumor (stage III), - Malignant tumor (stage Ia), - Metastasis, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade Stage TNM Type †
A1 1 M 56 Liver Normal liver tissue – – – Normal
A2 2 F 35 Liver Normal liver tissue – – – Normal
A3 3 M 40 Liver Normal liver tissue – – – Normal
A4 4 M 57 Liver Hepatocellular edema – – – Borderline
A5 5 M 36 Liver Hepatocellular edema with fatty degeneration – – – Borderline
A6 6 M 56 Liver Chronic active hepatitis – – – Inflammation
A7 7 F 58 Liver Chronic active hepatitis – – – Inflammation
A8 8 M 34 Liver Chronic active hepatitis with early hepatic cirrhosis – – – Inflammation
A9 9 M 57 Liver Nodular cirrhosis – – – Cirrhosis
A10 10 M 61 Liver Nodular cirrhosis – – – Cirrhosis
A11 11 M 49 Liver Nodular cirrhosis – – – Cirrhosis
A12 12 M 32 Liver Cavernous hemangioma – – – Benign
B1 13 M 56 Liver Normal liver tissue – – – Normal
B2 14 F 35 Liver Normal liver tissue – – – Normal
B3 15 M 40 Liver Normal liver tissue – – – Normal
B4 16 M 57 Liver Hepatocellular edema – – – Borderline
B5 17 M 36 Liver Hepatocellular edema with fatty degeneration – – – Borderline
B6 18 M 56 Liver Chronic active hepatitis – – – Inflammation
B7 19 F 58 Liver Chronic active hepatitis – – – Inflammation
B8 20 M 34 Liver Chronic active hepatitis with early hepatic cirrhosis – – – Inflammation
B9 21 M 57 Liver Nodular cirrhosis – – – Cirrhosis
B10 22 M 61 Liver Nodular cirrhosis – – – Cirrhosis
B11 23 M 49 Liver Nodular cirrhosis – – – Cirrhosis
B12 24 M 32 Liver Cavernous hemangioma – – – Benign
C1 25 M 41 Liver Hepatocellular carcinoma 1 III T3N0M0 Malignant
C2 26 M 68 Liver Hepatocellular carcinoma 1 II T2N0M0 Malignant
C3 27 F 42 Liver Hepatocellular carcinoma 1 II T2N0M0 Malignant
C4 28 M 72 Liver Hepatocellular carcinoma 1 II T2N0M0 Malignant
C5 29 M 62 Liver Hepatocellular carcinoma 1–2 II T2N0M0 Malignant
C6 30 M 40 Liver Hepatocellular carcinoma 1 II T2N0M0 Malignant
C7 31 M 52 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
C8 32 M 49 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
C9 33 M 37 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
C10 34 F 98 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
C11 35 M 57 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
C12 36 M 54 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
D1 37 M 41 Liver Hepatocellular carcinoma 1 III T3N0M0 Malignant
D2 38 M 68 Liver Hepatocellular carcinoma 1 II T2N0M0 Malignant
D3 39 F 42 Liver Hepatocellular carcinoma 1 II T2N0M0 Malignant
D4 40 M 72 Liver Hepatocellular carcinoma 1 II T2N0M0 Malignant
D5 41 M 62 Liver Hepatocellular carcinoma 1–2 II T2N0M0 Malignant
D6 42 M 40 Liver Hepatocellular carcinoma 1 II T2N0M0 Malignant
D7 43 M 52 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
D8 44 M 49 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
D9 45 M 37 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
D10 46 F 98 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
D11 47 M 57 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
D12 48 M 54 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
E1 49 F 44 Liver Hepatocellular carcinoma 2 I T1N0M0 Malignant
E2 50 M 50 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
E3 51 M 43 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
E4 52 M 26 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
E5 53 M 50 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
E6 54 M 38 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
E7 55 F 61 Liver Hepatocellular carcinoma 3 I T1N0M0 Malignant
E8 56 M 62 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
E9 57 M 42 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
E10 58 M 50 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
E11 59 M 48 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
E12 60 M 53 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
F1 61 F 44 Liver Hepatocellular carcinoma 2 I T1N0M0 Malignant
F2 62 M 50 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
F3 63 M 43 Liver Hepatocellular carcinoma 2 II T2N0M0 Malignant
F4 64 M 26 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
F5 65 M 50 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
F6 66 M 38 Liver Hepatocellular carcinoma 2 III T3N0M0 Malignant
F7 67 F 61 Liver Hepatocellular carcinoma 3 I T1N0M0 Malignant
F8 68 M 62 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
F9 69 M 42 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
F10 70 M 50 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
F11 71 M 48 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
F12 72 M 53 Liver Hepatocellular carcinoma 3 III T3N0M0 Malignant
G1 73 M 63 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
G2 74 M 64 Liver Clear cell carcinoma 2 III T3N0M0 Malignant
G3 75 M 57 Liver Clear cell carcinoma 2 I T1N0M0 Malignant
G4 76 M 65 Liver Clear cell carcinoma 2 III T3N0M0 Malignant
G5 77 F 73 Liver Hepatocholangiocarcinoma 2 I T1N0M0 Malignant
G6 78 M 60 Liver Hepatocholangiocarcinoma 2 II T2N0M0 Malignant
G7 79 F 54 Liver Hepatocholangiocarcinoma 2 III T3N0M0 Malignant
G8 80 F 49 Liver Hepatocholangiocarcinoma (sparse) – I T1N0M0 Malignant
G9 81 M 58 Liver Metastatic adenocarcinoma from colon 2 – – Metastasis
G10 82 F 58 Liver Metastatic adenocarcinoma from colon 3 – – Metastasis
G11 83 M 68 Liver Metastatic adenocarcinoma from stomach 2 – – Metastasis
G12 84 M 36 Liver Leiomyosarcoma – Ia T1N0M0 Malignant
H1 85 M 63 Liver Hepatocellular carcinoma 3 II T2N0M0 Malignant
H2 86 M 64 Liver Clear cell carcinoma 2 III T3N0M0 Malignant
H3 87 M 57 Liver Clear cell carcinoma 2 I T1N0M0 Malignant
H4 88 M 65 Liver Clear cell carcinoma 2 III T3N0M0 Malignant
H5 89 F 73 Liver Hepatocholangiocarcinoma 2 I T1N0M0 Malignant
H6 90 M 60 Liver Hepatocholangiocarcinoma 2 II T2N0M0 Malignant
H7 91 F 54 Liver Hepatocholangiocarcinoma 2 III T3N0M0 Malignant
H8 92 F 49 Liver Hepatocholangiocarcinoma (sparse) – I T1N0M0 Malignant
H9 93 M 58 Liver Metastatic adenocarcinoma from colon 2 – – Metastasis
H10 94 F 58 Liver Metastatic adenocarcinoma from colon 3 – – Metastasis
H11 95 M 68 Liver Metastatic adenocarcinoma from stomach 2 – – Metastasis
H12 96 M 36 Liver Leiomyosarcoma – Ia T1N0M0 Malignant
– – M 58 Skin Malignant melanoma (tissue marker) – Malignant

† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array:
© 2003 - 2013 US Biomax Inc.   custsrv@biomax.us   Tel: (800) 935-1357 | Privacy Policy

Authorize.Net Seal Starfield Seal